An interventional study of Heart monitor and No heart monitor in Acute Myocardial Infarction, sponsored by Instituto de Cardiologia do Rio Grande do Sul. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-04-08.
Sponsored by Instituto de Cardiologia do Rio Grande do Sul · Not applicable, Interventional, and Prevention
Verify the effectiveness of a Heart Monitor in preventing events in patients over 18 years after acute myocardial infarction in a clinical unit. Patients with neurological disease or congenital heart disease we excluded from the study.
Heart Monitor can detect early intercurrences. Objective: To verify the effectiveness of a Heart Monitoring system in preventing events in patients after acute myocardial infarction. Methodology: This is a randomized clinical trial to be developed in a clinical unit and will include patients over 18 years , post-acute myocardial infarction who were transferred from the ICU emergency or hemodynamic to clinical unit. Patients with neurological disease or congenital heart disease will be excluded from the study.
Exclusion Criteria:
We used the device (heart monitor) in the patients with myocardial infarction.
Device: Heart monitor
No heart monitor device in the patients with myocardial infarction (control).
Device: No heart monitor
Use of heart monitor device in the patients after acute myocardium infarct.
Also known as: Heart monitor device
Standard monitoring by nurses.
Also known as: No heart monitor device
Heart rhythm monitoring
Evaluating the effectiveness of a heart monitoring device in the prevention and detection of events in patients after acute myocardial infarction
Time frame: One year
No study locations are listed for this record.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto de Cardiologia do Rio Grande do Sul